Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2024-08-07

Clinical Trial Update: Safety and Effectiveness of Minimally Invasive Micro Sclerostomy (MIMS®) to Reduce Intraocular Pressure in Open-Angle Glaucoma Which is Not Controlled Despite Polypharmacy [NA]

View source ↗

Summary

An update on a clinical trial evaluating the Minimally Invasive Micro Sclerostomy (MIMS) procedure to reduce intraocular pressure in primary open-angle glaucoma…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Snippet

Sponsor: Sanoculis Ltd | Conditions: Primary Open Angle Glaucoma, Open Angle Glaucoma | NA | Status: RECRUITING